Flunixin Meglumine for Alpaca: Banamine Uses, Dosing & Risks

This information is for educational purposes only. Never give your pet any medication without your veterinarian's guidance. Dosing, frequency, and safety depend on your pet's specific health profile.

Flunixin meglumine, often recognized by the brand name Banamine, is a prescription nonsteroidal anti-inflammatory drug (NSAID). Your vet may use it in alpacas to help reduce pain, inflammation, and fever. In veterinary medicine, flunixin is especially valued for visceral pain and inflammatory conditions, but it needs careful dosing and monitoring because NSAIDs can also affect the stomach, intestines, kidneys, and blood flow.

In alpacas and other camelids, flunixin use is generally extra-label in the United States. That means your vet may prescribe it legally under a valid veterinarian-client-patient relationship, but the drug is not specifically labeled for alpacas. Because alpacas are food-producing animals under US regulations, your vet also has to consider meat and milk withdrawal guidance and residue avoidance.

This is not a medication to start on your own from a barn supply shelf. The right route, dose, and treatment length depend on why your alpaca needs it, whether dehydration is present, and whether there are ulcers, kidney concerns, pregnancy issues, or other medications already on board.

Your vet may use flunixin meglumine in alpacas for short-term control of pain and inflammation. Common situations include abdominal pain, musculoskeletal pain, fever, post-procedure discomfort, and inflammatory illness where reducing prostaglandin-driven inflammation may help the alpaca feel better and stabilize supportive care.

It is also sometimes chosen when your vet is concerned about endotoxemia, severe systemic inflammation, or painful gastrointestinal disease. In those cases, flunixin is usually only one part of the plan. Fluids, diagnostics, nursing care, and treatment of the underlying cause matter just as much.

Flunixin does not fix the reason an alpaca is painful. It can also mask worsening signs, which is why rechecks are important. If an alpaca has colic signs, is down, is not eating, has dark stool, or seems weak or dehydrated, see your vet immediately rather than relying on pain medication alone.

In camelid references, flunixin meglumine is commonly listed at 1.1-2.2 mg/kg IV every 24 hours. That said, the exact dose your vet chooses may be lower, higher within that range, or less frequent depending on the alpaca's age, hydration status, pregnancy status, pain source, and overall risk profile. Intravenous use is often preferred in hospital or field settings because it gives predictable absorption and avoids some injection-site concerns.

For practical context, an alpaca weighing 70 kg would fall in a rough reference range of 77-154 mg per dose, which equals about 1.5-3.1 mL of a 50 mg/mL injectable product. An alpaca weighing 90 kg would fall around 99-198 mg, or about 2.0-4.0 mL of a 50 mg/mL product. These examples are not home dosing instructions. Concentration, route, frequency, and duration must come from your vet.

Flunixin is usually used for short courses, not long-term daily pain management. Repeated NSAID dosing raises the risk of stomach or intestinal ulceration and kidney injury, especially if the alpaca is dehydrated, septic, or already eating poorly. If your alpaca misses a dose, do not double the next one unless your vet specifically tells you to.

Possible side effects in alpacas are similar to those seen with other NSAIDs. Watch for reduced appetite, teeth grinding, depression, diarrhea, dark or tarry stool, belly pain, weakness, or worsening dehydration. These can point to gastrointestinal irritation or ulceration. Kidney injury is another concern, especially in sick alpacas with poor circulation or fluid losses.

Injection-related problems can also happen. If the product is given outside the vein, tissue irritation may occur. Any swelling, pain, heat, or skin damage at an injection site should be reported to your vet.

See your vet immediately if your alpaca becomes weak, stops eating, develops black stool, seems more painful after treatment, urinates less, or collapses. Those signs can mean the underlying disease is worsening, the medication is not enough, or the alpaca is having a serious adverse effect.

Flunixin should be used carefully with other NSAIDs such as meloxicam, phenylbutazone, or ketoprofen. Combining NSAIDs, or stacking one too soon after another, increases the risk of stomach ulcers, intestinal injury, and kidney damage. It should also be used cautiously with corticosteroids like dexamethasone because that combination can sharply increase ulcer risk.

Your vet will also think carefully before pairing flunixin with drugs that may affect the kidneys or circulation, including some aminoglycoside antibiotics such as gentamicin or amikacin, especially in dehydrated or critically ill alpacas. Diuretics and other medications that reduce kidney perfusion may also raise concern.

Because alpacas are food animals, medication decisions involve more than comfort and safety. Your vet may need to adjust the plan based on residue avoidance, withdrawal recommendations, and legal extra-label use rules. Always tell your vet about every product your alpaca has received, including dewormers, antibiotics, supplements, and any pain medication already given.